Yatharth Hospital Board Approves Q1 FY27 Results, Interim Dividend, and ESOP Scheme
Yatharth Hospital announced Q1 FY27 results, reporting standalone revenue of ₹1,763.08 million and consolidated revenue of ₹3,926.54 million. The company declared an interim dividend of ₹0.50 per share, with a record date of August 14, 2026. An ESOP 2026 scheme was approved, and M/s Subodh Kumar & Co. re-appointed as Cost Auditor. Additionally, the company acquired a 250-bed under-construction hospital in Gurugram for ₹1,000 million (₹100 crore).
The approval of financial results, declaration of dividend, and a significant acquisition like a new hospital are material events that can significantly impact the company's financial performance, market position, and shareholder value.
The announcement includes positive developments such as the approval of quarterly results, declaration of an interim dividend, and a strategic acquisition, all of which are generally viewed favorably by investors.
Yatharth Hospital & Trauma Care Services Limited announced the outcome of its Board Meeting held on August 10, 2026. The Board approved the unaudited financial results for the first quarter ended June 30, 2026, both standalone and consolidated. Additionally, the Board declared a first interim dividend of ₹0.50 per equity share for the Financial Year 2026-27, with a record date fixed for August 14, 2026. The company also approved the introduction of the “Yatharth Hospital & Trauma Care Services Employees Stock Option Scheme - 2026” (ESOP 2026), subject to shareholder approval. The Board re-appointed M/s Subodh Kumar & Co. as the Cost Auditor for the Financial Year 2026-27. The Board meeting commenced at 02:33 PM (IST) and concluded at 03:41 PM (IST). The consolidated financial results show a revenue from operations of ₹3,926.54 million for the quarter ended June 30, 2026, and a profit after tax of ₹454.23 million. The standalone financial results reported a revenue from operations of ₹1,763.08 million and a profit after tax of ₹281.68 million for the same period. In a significant development, the company also acquired an under-construction hospital in Gurugram for ₹1,000 million (₹100 crore), which is expected to commence operations within twelve months and will have a capacity of 250 beds.
The financial results indicate a growth in revenue for both standalone and consolidated operations compared to the previous year's quarter. The declaration of an interim dividend demonstrates a commitment to returning value to shareholders. The introduction of the ESOP 2026 scheme aims to incentivize and retain key employees. The acquisition of a new hospital in Gurugram signifies the company's expansion strategy, enhancing its bed capacity and market presence.
The company also noted that the Income Tax Department conducted searches in October 2023, and while assessment orders have been issued for certain years, the company believes no material liability is expected and has filed appeals against the orders. The limited review reports for both standalone and consolidated financial results were issued by M/s. M S K A & Associates LLP.
What to do with a filing like this
Yatharth Hospital & Trauma Care Services Limited filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it high impact, which is the band that most often changes something.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Yatharth Hospital & Trauma Care Services Limited. Read the original for the full detail.